MP Biomedicals Are Approved to Export Bovine Blood Products to China

< Back to News

Aug 23, 2017
Santa Ana, California, August 23, 2017 - MP Biomedicals has been approved for exports of bovine blood proteins into China. This approval, granted last month to 16 companies by the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (AQSIQ) allows MP Biomedicals to export its entire range of bovine blood proteins, comprising of BSA, Transferrin, Thrombin, IgG and Fibrinogen into China. MP Biomedical’s protein products are used in the Life Science market for the manufacture of therapeutic monoclonal antibodies, vaccines, infectious disease media, diagnostic kits, cell culture media and other research purposes. Adhering to compliance requirements specified in the New Zealand Ministry for Primary Industries OMAR (Overseas Market Access Requirement), MP Biomedicals will begin export of the bovine protein products from New Zealand immediately to support the industry growth in these markets. Learn more about this product range or contact us for further information.